pentobarbital will minimize the extent or outcome of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Use of different therapies is strongly encouraged when linagliptin is always to be administered with a CYP3A4 inducerPhenobarbital seems to interfere Using the absorption of orally administered griseofulvin, … Read More